Results 81 to 90 of about 999 (168)
: Carbocysteine lysine salt monohydrate (SCMC-Lys) is a well-known mucoactive drug whose therapeutic efficacy is commonly related to the ability of SCMC-Lys to replace fucomucins by sialomucins.
Mengozzi, Manuela +9 more
core +1 more source
Antioxidants and Mucolytics in COPD Management: When (if ever) and in Whom?
Chronic obstructive pulmonary disease (COPD) is a major cause of morbidity and mortality worldwide. Oxidative stress is an important mechanism in the pathogenesis of this disease.
Hillas, Georgios +3 more
core +1 more source
Allergic bronchopulmonary mycosis caused by <i>Schizophyllum commune</i> in a patient with severe food allergy and asthma. [PDF]
Ohkoshi Y +7 more
europepmc +1 more source
Pneumonic Injury and Repair: A Synopsis. [PDF]
Barabutis N.
europepmc +1 more source
A Systematic Review of Pediatric Acute Generalized Exanthematous Pustulosis. [PDF]
Cheung YS, Leung AJ, Liau MM.
europepmc +1 more source
Efficacy of Carbocisteine in Reducing Exacerbations in Chronic Obstructive Pulmonary Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. [PDF]
Kow CS, Hasan SS, Thiruchelvam K.
europepmc +1 more source
AN OPEN STUDY INVOLVED 14 ITALIAN CENTERS AND 348 HOSPITALIZED PATIENTS OF BOTH SEXES, AGED 61.57 +- 12.54 (MEAN VALUE) WITH COPD IN ACUTE PHASE. ALL PATIENTS WERE TREATED WITH YHE CARBOCYSTEINE AND SOBREROL COMBINATION FOR 10 CONSECUTIVE DAYS.
CASCIATO G +37 more
core
Field survey on warnings to prevent drug abuse when selling over-the-counter drugs at drugstores. [PDF]
Nagashima K, Nasu H, Sekine Y.
europepmc +1 more source

